GC Pharma pledges free Covid-19 treatment, if it's approvedGC Pharma on Monday promised to offer its Covid-19 treatments for free to patients in Korea once it completes development.
The Yongin, Gyeonggi-based pharmaceutical company's treatment candidate, called GC5131A, is a hyperimmune globulin that is made with immune proteins collected from recovered Covid-19 patients.
GC is the first Korean drugmaker to make such a pledge about a potential Covid-19 treatment.
The decision, the company said, is intended to contribute to public health efforts to rein in the coronavirus pandemic, adding that it won’t place any cap on the quantity of the treatments to be circulated.
The pharmaceutical unit is hoping for commercialization the drug by the second half of 2020.
BY PARK EUN-JEE [email@example.com]
More in Industry
Chuseok delivery strike canceled as headcount increased
BMW Motorrad channels 1936 for its latest bike
Battery business IPO won't affect LG Chem's controlling stake, company says
Hyundai Construction Equipment signs Algeria forklift deal
FSS permits financial sector workers to use networks remotely